tirzepatide discontinuation weight regain study for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Change in Glycemic Parameters by

We aim to identify molecular signatures associated with recurrence, uncovering potential therapeutic targets

Schedule a Consultation If you are interested in learning whether the GLOW Protocol may be right for you, contact Stonebridge Medical in The Colony, TX to schedule a consultation

Omega-3-rich foods, adequate protein, and a variety of vegetables support both joint health and weight management

Yet navigating this emerging therapeutic avenue on your own can feel overwhelming, especially when youre already managing a demanding career and complex health goals

146 episodes triggered a specialist referral upon discharge

Non-GLP-1 oral medications: Phentermine/topiramate, naltrexone/bupropion, and orlistat typically 512% average loss in trials, each with different side-effect profiles (NIDDK prescription medications overview)